The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Reid Laurence since 2012.
This trader's CIK number is 1492749.
At the time of last reporting, Reid Laurence was the President and Chief Executive of Decibel Therapeutics, Inc.. (stock ticker symbol DBTX).
Also see all insider trading activities at Decibel Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2014 | ALNY | 0 | $0 | 57,400 | $4,232,933 | 54,252 | $542,519 |
2014 | ALNY | 0 | $0 | 0 | $0 | 17,000 | $271,830 |
2013 | ALNY | 0 | $0 | 23,500 | $995,306 | 23,500 | $286,865 |
2012 | ALNY | 930 | $9,997 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2021 | DBTX | 10,000 | $76,400 | 0 | $0 | 0 | $0 |
1. Alnylam Pharmaceuticals, Inc. (ALNY)
2. Decibel Therapeutics, Inc. (DBTX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2014-12-31 | ALNY | Option Ex | 17,000 | 15.99 | 271,830 |
2014-11-18 | ALNY | Option Ex | 10,000 | 10.74 | 107,430 |
2014-11-18 | ALNY | Sale | 10,000 | 91.06 | 910,570 |
2014-08-18 | ALNY | Option Ex | 13,500 | 8.12 | 109,619 |
2014-08-18 | ALNY | Sale | 13,500 | 67.32 | 908,793 |
2014-05-19 | ALNY | Option Ex | 13,500 | 8.12 | 109,619 |
2014-05-19 | ALNY | Sale | 13,500 | 57.54 | 776,776 |
2014-02-19 | ALNY | Option Ex | 13,500 | 11.54 | 155,857 |
2014-02-19 | ALNY | Sale | 20,400 | 80.23 | 1,636,794 |
2013-12-30 | ALNY | Option Ex | 3,752 | 15.99 | 59,994 |
2013-11-13 | ALNY | Option Ex | 13,500 | 15.99 | 215,865 |
2013-11-13 | ALNY | Sale | 13,500 | 53.36 | 720,306 |
2013-05-28 | ALNY | Option Ex | 5,000 | 7.10 | 35,500 |
2013-05-28 | ALNY | Sale | 5,000 | 30.00 | 150,000 |
2013-02-08 | ALNY | Option Ex | 5,000 | 7.10 | 35,500 |
2013-02-08 | ALNY | Sale | 5,000 | 25.00 | 125,000 |
2012-02-21 | ALNY | Buy | 930 | 10.75 | 9,997 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-09-15 | DBTX | Buy | 10,000 | 7.64 | 76,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reid Laurence (President and Chief Executive of Decibel Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.